FdaApplication
ANDA 202101
Identifiers
- fda_app_no: ANDA202101
Properties
| Property | Value |
|---|---|
| applicant_name | ALEMBIC PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2015-04-28 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARIPIPRAZOLE | ARIPIPRAZOLE | 2MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 10MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 5MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 15MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 20MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 30MG | TABLET;ORAL |
6 products